Live Webinar on June 27: From Data to Insights: Leveraging GenAI in Real-World Evidence (RWE) Studies
DATE
May 29, 2024
Munich – Wednesday, May 29, 2024 – eCOA and EDC software company Climedo is inviting professionals from pharmaceutical companies and CROs to join a free 60-minute webcast about the revolutionary potential of Generative AI (GenAI) in healthcare, specifically its application in Real-World Evidence (RWE) on June 27.
GenAI is rapidly transforming medical research, diagnosis and treatment methodologies. But how can it be utilized in RWE studies to enhance trial efficiency, improve data analysis capabilities and drive meaningful discoveries? Climedo’s upcoming webinar aims to answer these questions and provide actionable insights.
In the next Climedo Connect webcast on June 27, 2024 at 3pm CET, Dragan Mileski, Co-Founder and CTO of Climedo, will present emerging trends and the technological outlook to help attendees grasp the potential of GenAI in transforming RWE studies.
Highlights of the webinar include:
- Understanding GenAI: A comprehensive overview of the fundamentals of GenAI.
- Top use cases for GenAI in post-market studies: Practical applications of GenAI in post-market studies, its role in drug safety monitoring, comparative effectiveness analysis and other critical areas.
- Best practices for incorporating GenAI in clinical research: Actionable strategies and best practices for seamlessly integrating GenAI into clinical trials.
Registration is free via this link and registrants will receive access to the presentation’s slide deck and recording afterwards. Specific questions and requests may be submitted ahead of the event by reaching out to us.
